Literature DB >> 26303089

Inherited forms of mineralocorticoid hypertension.

Maria-Christina Zennaro1, Sheerazed Boulkroun2, Fabio Fernandes-Rosa3.   

Abstract

Aldosterone plays an essential role in the maintenance of fluid and electrolyte homeostasis in the distal nephron. Monogenic forms of mineralocorticoid hypertension result from genetic defects leading to excessive production of aldosterone (or other mineralocorticoids) from the adrenal cortex or to illegitimate mineralocorticoid effects in the kidney. They are characterized in the majority of cases by early onset, severe or resistant hypertension and associated with suppressed renin levels. Depending on their causes, these diseases are distinguished at the clinical and biochemical level and differently affect aldosterone levels and kalemia. The diagnosis is confirmed by genetic testing, which allows in many cases targeted treatment to prevent severe cardiovascular consequences of high blood pressure or aldosterone excess. In this review we describe the different forms of inherited mineralocorticoid hypertension, providing an overview of their clinical and biochemical features, their underlying genetic defects and specific therapeutic options.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  11β-hydroxysteroid dehydrogenase; apparent mineralocorticoid excess; congenital adrenal hyperplasia; epithelial sodium channel; familial hyperkalemic hypertension; mineralocorticoid receptor; primary aldosteronism

Mesh:

Year:  2015        PMID: 26303089     DOI: 10.1016/j.beem.2015.04.010

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  10 in total

Review 1.  Primary aldosteronism: a common cause of resistant hypertension.

Authors:  Gregory A Kline; Ally P H Prebtani; Alexander A Leung; Ernesto L Schiffrin
Journal:  CMAJ       Date:  2017-06-05       Impact factor: 8.262

Review 2.  Congenital adrenal hyperplasia causing hypertension: an illustrative review.

Authors:  Laura Hinz; Daniele Pacaud; Gregory Kline
Journal:  J Hum Hypertens       Date:  2017-12-18       Impact factor: 3.012

Review 3.  Pathophysiology of bilateral hyperaldosteronism.

Authors:  Kazutaka Nanba; William E Rainey
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-06-01       Impact factor: 3.626

4.  A Novel Frame-Shift Mutation in SCNN1B Identified in a Chinese Family Characterized by Early-Onset Hypertension.

Authors:  Yi-Ting Lu; Xin-Chang Liu; Ze-Ming Zhou; Di Zhang; Lin Sun; Ying Zhang; Peng Fan; Lin Zhang; Ya-Xin Liu; Fang Luo; Xian-Liang Zhou
Journal:  Front Cardiovasc Med       Date:  2022-06-14

5.  CACNA1H Mutations Are Associated With Different Forms of Primary Aldosteronism.

Authors:  Georgios Daniil; Fabio L Fernandes-Rosa; Jean Chemin; Iulia Blesneac; Jacques Beltrand; Michel Polak; Xavier Jeunemaitre; Sheerazed Boulkroun; Laurence Amar; Tim M Strom; Philippe Lory; Maria-Christina Zennaro
Journal:  EBioMedicine       Date:  2016-10-04       Impact factor: 8.143

Review 6.  Liddle Syndrome: Review of the Literature and Description of a New Case.

Authors:  Martina Tetti; Silvia Monticone; Jacopo Burrello; Patrizia Matarazzo; Franco Veglio; Barbara Pasini; Xavier Jeunemaitre; Paolo Mulatero
Journal:  Int J Mol Sci       Date:  2018-03-11       Impact factor: 5.923

7.  Liddle syndrome misdiagnosed as primary aldosteronism resulting from a novel frameshift mutation of SCNN1B.

Authors:  Peng Fan; Chao-Xia Lu; Di Zhang; Kun-Qi Yang; Pei-Pei Lu; Ying Zhang; Xu Meng; Su-Fang Hao; Fang Luo; Ya-Xin Liu; Hui-Min Zhang; Lei Song; Jun Cai; Xue Zhang; Xian-Liang Zhou
Journal:  Endocr Connect       Date:  2018-12       Impact factor: 3.335

Review 8.  Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia.

Authors:  Mattia Barbot; Pierluigi Mazzeo; Martina Lazzara; Filippo Ceccato; Carla Scaroni
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-01       Impact factor: 6.055

9.  Clinical and Genetic Analysis of a Patient With Coexisting 17a-Hydroxylase/17,20-Lyase Deficiency and Moyamoya Disease.

Authors:  Jiaming Huang; Danli Zhou; Nan Dong; Chenzhao Ding; Yan Liu; Fangping Li
Journal:  Front Genet       Date:  2022-08-30       Impact factor: 4.772

Review 10.  Hypokalemia: a clinical update.

Authors:  Efstratios Kardalas; Stavroula A Paschou; Panagiotis Anagnostis; Giovanna Muscogiuri; Gerasimos Siasos; Andromachi Vryonidou
Journal:  Endocr Connect       Date:  2018-03-14       Impact factor: 3.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.